Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 1,939 shares, a drop of 26.5% from the January 29th total of 2,638 shares. Based on an average daily volume of 7,528 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 7,528 shares, the short-interest ratio is currently 0.3 days.
Hikma Pharmaceuticals Stock Performance
OTCMKTS:HKMPY opened at $35.77 on Monday. Hikma Pharmaceuticals has a 52 week low of $35.76 and a 52 week high of $56.94. The stock’s fifty day moving average is $42.44 and its two-hundred day moving average is $44.37.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- 3 Signs You May Want to Switch Financial Advisors
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- America’s 1776 happening again
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
